Georg Pfeiler-Georg
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Influence of histopathological changes after neoadjuvant chemotherapy on the survival of breast cancer patients.
Journal: Cancer treatment and research communications
Published: July 30, 2024
Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria.
Journal: BMC cancer
Published: March 03, 2022
Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2+ Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab.
Journal: Clinical breast cancer
Published: April 28, 2021
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.
Journal: Breast (Edinburgh, Scotland)
Published: July 12, 2019
Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Journal: Breast cancer research : BCR
Published: November 06, 2014
Impact of AdipoR1 expression on breast cancer development.
Journal: Gynecologic oncology
Published: August 13, 2009
Showing 1-8 of 8
Last Updated: 09/26/2026